Jeffrey S. Parkin

Array ( [id] => 657616 [patent_doc_number] => 07105169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Cyanovirin conjugates and matrix-anchored cyanovirin and related compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 09/951189 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 21517 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105169.pdf [firstpage_image] =>[orig_patent_app_number] => 09951189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 633860 [patent_doc_number] => 07128915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-31 [patent_title] => 'Membrane virus host range mutations and their uses as vaccine substrates' [patent_app_type] => utility [patent_app_number] => 09/952782 [patent_app_country] => US [patent_app_date] => 2001-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8269 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/128/07128915.pdf [firstpage_image] =>[orig_patent_app_number] => 09952782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6650386 [patent_doc_number] => 20030008275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-09 [patent_title] => 'Attenuated HIV strains and use thereof' [patent_app_type] => new [patent_app_number] => 09/948977 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5391 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20030008275.pdf [firstpage_image] =>[orig_patent_app_number] => 09948977 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5969040 [patent_doc_number] => 20020091097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Nucleic acids for the prevention and treatment of sexually transmitted diseases' [patent_app_type] => new [patent_app_number] => 09/949194 [patent_app_country] => US [patent_app_date] => 2001-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20838 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091097.pdf [firstpage_image] =>[orig_patent_app_number] => 09949194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6724940 [patent_doc_number] => 20030207252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'VPR function and activity' [patent_app_type] => new [patent_app_number] => 09/935100 [patent_app_country] => US [patent_app_date] => 2001-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31976 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207252.pdf [firstpage_image] =>[orig_patent_app_number] => 09935100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6208333 [patent_doc_number] => 20020071844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-13 [patent_title] => 'Method of preventing and treating viral diseases' [patent_app_type] => new [patent_app_number] => 09/919441 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3648 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20020071844.pdf [firstpage_image] =>[orig_patent_app_number] => 09919441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6274738 [patent_doc_number] => 20020106374 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Compositions and methods for inhibition of HIV-1 infection' [patent_app_type] => new [patent_app_number] => 09/912824 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 22357 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106374.pdf [firstpage_image] =>[orig_patent_app_number] => 09912824 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242010 [patent_doc_number] => 20020045161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Fluorescence resonance energy transfer screening assay for the identification of HIV-1 envelope glycoprotein-medicated cell' [patent_app_type] => new [patent_app_number] => 09/904356 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15720 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 189 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045161.pdf [firstpage_image] =>[orig_patent_app_number] => 09904356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7407332 [patent_doc_number] => 20040106100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Dna vaccines encoding hiv accessory proteins' [patent_app_type] => new [patent_app_number] => 10/312197 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14843 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106100.pdf [firstpage_image] =>[orig_patent_app_number] => 10312197 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6141591 [patent_doc_number] => 20020001817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-03 [patent_title] => 'Assay for specific strains of multiple disease related conformations of a protein' [patent_app_type] => new [patent_app_number] => 09/901865 [patent_app_country] => US [patent_app_date] => 2001-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24073 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0001/20020001817.pdf [firstpage_image] =>[orig_patent_app_number] => 09901865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701081 [patent_doc_number] => 20030223961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof' [patent_app_type] => new [patent_app_number] => 09/899575 [patent_app_country] => US [patent_app_date] => 2001-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 114 [patent_figures_cnt] => 114 [patent_no_of_words] => 41171 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20030223961.pdf [firstpage_image] =>[orig_patent_app_number] => 09899575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 318467 [patent_doc_number] => 07521176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Methods for characterizing the viral infectivity status of a host' [patent_app_type] => utility [patent_app_number] => 09/893604 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3340 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521176.pdf [firstpage_image] =>[orig_patent_app_number] => 09893604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429470 [patent_doc_number] => 20020127238 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'HIV-1 vaccines and screening methods therefor' [patent_app_type] => new [patent_app_number] => 09/891609 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13551 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127238.pdf [firstpage_image] =>[orig_patent_app_number] => 09891609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7356090 [patent_doc_number] => 20040013683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Derivatives of soluble T-4' [patent_app_type] => new [patent_app_number] => 09/891119 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 28242 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013683.pdf [firstpage_image] =>[orig_patent_app_number] => 09891119 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6898347 [patent_doc_number] => 20010046512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-29 [patent_title] => 'Compounds capable of inhibiting HIV-1 infection' [patent_app_type] => new [patent_app_number] => 09/891062 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9248 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20010046512.pdf [firstpage_image] =>[orig_patent_app_number] => 09891062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968990 [patent_doc_number] => 20020091073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Method to limit immunodeficiency virus infection and compounds therefor' [patent_app_type] => new [patent_app_number] => 09/881573 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8779 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20020091073.pdf [firstpage_image] =>[orig_patent_app_number] => 09881573 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774248 [patent_doc_number] => 20030017586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Novel 3\' terminal sequence of hepatitis C virus genome and diagnostic and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 09/880567 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21764 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017586.pdf [firstpage_image] =>[orig_patent_app_number] => 09880567 [rel_patent_id] =>[rel_patent_doc_number] =>)